← back to search

Luca Digiacomo

Università Campus Bio-Medico · IT
Area of research
Biomaterials · Molecular Biology
Research interest
Research focused on Pancreatic cancer and Corona (planetary geology), with related work in Graphene, Liposome, Pancreatic ductal adenocarcinoma. Notable publications include 'Disease-specific protein corona sensor arrays may have disease detection capacity', 'Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells', and 'A protein corona-enabled blood test for early cancer detection'.
h-index
citations
836
works
24
NIH funding
primary concept
email

Recent publications

Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification
Nanoscale 2025cited by 3position: firstdoi
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
Cancers 2023cited by 9position: firstdoi
Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties <i>In Vivo</i>
ACS Nano 2022cited by 61position: middledoi
Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins
Cancers 2022cited by 21position: middledoi
Magnetic Levitation of Personalized Nanoparticle–Protein Corona as an Effective Tool for Cancer Detection
Nanomaterials 2022cited by 14position: middledoi
Protein corona profile of graphene oxide allows detection of glioblastoma multiforme using a simple one-dimensional gel electrophoresis technique: a proof-of-concept study
Biomaterials Science 2021cited by 23position: middledoi
Optimal centrifugal isolating of liposome–protein complexes from human plasma
Nanoscale Advances 2021cited by 21position: firstdoi
Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles
Biointerphases 2021cited by 20position: firstdoi
A Proteomic Study on the Personalized Protein Corona of Liposomes. Relevance for Early Diagnosis of Pancreatic DUCTAL Adenocarcinoma and Biomarker Detection
Journal of Nanotheranostics 2021cited by 16position: firstdoi
Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
Cancers 2021cited by 14position: firstdoi
Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
Frontiers in Bioengineering and Biotechnology 2020cited by 70position: middledoi
A protein corona sensor array detects breast and prostate cancers
Nanoscale 2020cited by 28position: firstdoi
Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
Cancers 2020cited by 28position: middledoi
Fine-Tuning of Nanoparticle-Protein Corona Composition: A New Strategy for the Development of Efficient in Vitro Diagnostic Testing for Early Pancreatic Cancer Detection
Journal of the American College of Surgeons 2020cited by 1position: middledoi
Disease-specific protein corona sensor arrays may have disease detection capacity
Nanoscale Horizons 2019cited by 111position: middledoi
Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection
Nanoscale 2019cited by 61position: middledoi
Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
Pharmaceutics 2019cited by 57position: middledoi
The biomolecular corona of gold nanoparticles in a controlled microfluidic environment
Lab on a Chip 2019cited by 54position: firstdoi
Combining Inflammatory Biomarkers and Laboratory Tests with Nanoparticle-Protein Corona Technology Makes a Significant Advance in Early Pancreatic Cancer Detection
Journal of the American College of Surgeons 2019cited by 0position: middledoi
Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study
Pancreatology 2018cited by 23position: middledoi
Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations
Advanced Biosystems 2018cited by 12position: middledoi
Nanoparticle-Blood Interactions: New Insights into Pancreatic Cancer Biology?
Journal of the American College of Surgeons 2018cited by 0position: middledoi
Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells
Nanoscale 2017cited by 96position: middledoi
A protein corona-enabled blood test for early cancer detection
Nanoscale 2016cited by 93position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniela Pozzi · Università Campus Bio-Medico24 papers (2016–2025)Giulio Caracciolo · Università Campus Bio-Medico24 papers (2016–2025)Damiano Caputo · Università Campus Bio-Medico21 papers (2016–2025)Roberto Coppola · Università Campus Bio-Medico17 papers (2016–2025)Sara Palchetti · Università Campus Bio-Medico13 papers (2016–2021) · 10 papers (2018–2022)Chiara Cascone · Università Campus Bio-Medico9 papers (2018–2021) · 9 papers (2018–2022)Erica Quagliarini · Università Campus Bio-Medico9 papers (2020–2025)Francesca Giulimondi · Università Campus Bio-Medico7 papers (2019–2025)Riccardo Zenezini Chiozzi · Utrecht University7 papers (2018–2022)Morteza Mahmoudi · Michigan State University6 papers (2018–2021) · 5 papers (2016–2022)Riccardo Di Santo · Università Campus Bio-Medico5 papers (2020–2022) · 4 papers (2021–2025)Alessandro Coppola · Università Campus Bio-Medico4 papers (2021–2022) · 3 papers (2017–2019)Vincenzo La Vaccara · Università Campus Bio-Medico3 papers (2021–2025)Angelina Di Carlo · Università Campus Bio-Medico2 papers (2019–2021) · 2 papers (2021–2022)